- Home
- AQST vs PEO Comparison
AQST vs PEO Comparison
Compare AQST & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- PEO
- Stock Information
- Founded
- AQST 2004
- PEO 1929
- Country
- AQST United States
- PEO United States
- Employees
- AQST N/A
- PEO N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- PEO Finance/Investors Services
- Sector
- AQST Health Care
- PEO Finance
- Exchange
- AQST Nasdaq
- PEO Nasdaq
- Market Cap
- AQST 502.6M
- PEO 603.2M
- IPO Year
- AQST 2018
- PEO N/A
- Fundamental
- Price
- AQST $3.82
- PEO $21.73
- Analyst Decision
- AQST Strong Buy
- PEO
- Analyst Count
- AQST 8
- PEO 0
- Target Price
- AQST $10.38
- PEO N/A
- AVG Volume (30 Days)
- AQST 1.5M
- PEO 35.4K
- Earning Date
- AQST 11-04-2024
- PEO 01-01-0001
- Dividend Yield
- AQST N/A
- PEO 5.93%
- EPS Growth
- AQST N/A
- PEO N/A
- EPS
- AQST N/A
- PEO N/A
- Revenue
- AQST $58,900,000.00
- PEO N/A
- Revenue This Year
- AQST $18.45
- PEO N/A
- Revenue Next Year
- AQST N/A
- PEO N/A
- P/E Ratio
- AQST N/A
- PEO N/A
- Revenue Growth
- AQST 22.56
- PEO N/A
- 52 Week Low
- AQST $1.84
- PEO $19.22
- 52 Week High
- AQST $6.23
- PEO $23.80
- Technical
- Relative Strength Index (RSI)
- AQST 37.08
- PEO 23.83
- Support Level
- AQST $3.56
- PEO $22.27
- Resistance Level
- AQST $5.29
- PEO $22.84
- Average True Range (ATR)
- AQST 0.24
- PEO 0.35
- MACD
- AQST -0.07
- PEO -0.17
- Stochastic Oscillator
- AQST 16.81
- PEO 5.33
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About PEO Adams Natural Resources Fund Inc.
Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.